Table 1 Demographic and clinicopathologic characteristics of the study population (n = 243)
From: Comparison of stage III mucinous and serous ovarian cancer: a case-control study
Characteristics | MOC | Serous EOC | Â |
|---|---|---|---|
Values, n (%) | Values, n (%) | p | |
Age, y (median, range) | 53.9 (18–77) | 53.4 (28–81) | 0.73 |
Menopausal status | |||
 Postmenopausal | 49 (60.5%) | 98 (60.5%) | 1.0 |
 Premenopausal | 32 (39.5%) | 64 (39.5%) | 1.0 |
CA 125 (IU/ml) (median, range) | 126 (4–4891) | 514 (8–27,580) | 0.022 |
Grade | |||
 1 | 29 (35.8%) | 58 (35.8%) | 1.0 |
 2–3 | 52 (64.2%) | 104 (64.2%) | 1.0 |
Stage | |||
 IIIA1 | 13 (16.1%) | 26 (16.1%) | 1.0 |
 IIIA2 | 6 (7.4%) | 12 (7.4%) | 1.0 |
 IIIB | 13 (16%) | 26 (16%) | 1.0 |
 IIIC | 49 (60.5%) | 98 (60.5%) | 1.0 |
Debulking | |||
 Optimal | 54 (66.7%) | 108 (66.7%) | 1.0 |
 Maximal | 27 (33.3%) | 54 (33.3%) | 1.0 |
Ascites | |||
 Present | 42 (51.9%) | 125 (77.2%) | < 0.001 |
 Absent | 39 (48.1%) | 37 (22.8%) | |
Peritoneal Cytology | |||
 Positive | 61 (75.3%) | 137 (84.6%) | 0.114 |
 Negative | 20 (24.7%) | 25 (15.4%) | |
Number of LNs removed (median, range) | 34 (19–96) | 49 (21–203) | < 0.001 |
 Pelvic LNs | 24 (10–75) | 32 (10–101) | 0.003 |
 Para-aortic LNs | 11 (5–54) | 15 (5–102) | < 0.001 |
Retroperitoneal LN metastases | |||
 Present | 21 (25.9%) | 91 (56.2%) | < 0.001 |
 Absent | 60 (74.1%) | 71 (43.8%) | |
Appendiceal Involvement | |||
 Present | 29 (35.8%) | 59 (36.4%) | 1.0 |
 Absent | 52 (64.2%) | 103 (63.6%) | |
Omental Involvement | |||
 Present | 61 (75.3%) | 113 (69.8%) | 0.451 |
 Absent | 20 (24.7%) | 49 (30.2%) | |
Peritoneal Involvement | |||
 Present | 57 (70.4%) | 103 (63.6%) | 0.318 |
 Absent | 24 (29.6%) | 59 (36.4%) | |
Status | |||
 Alive | 32 (39.5%) | 112 (69.1%) |  |
 Dead | 49 (60.5%) | 50 (30.9%) |  |
Follow-up, months (median, range) | 21 (1–216) | 46 (1–121) |  |